Research Article
Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer
Figure 2
Anlotinib combined with 5-FU induces cell apoptosis in the H446 cells. The cells were treated with anlotinib and 5-FU or combination of both for 24 hours. Apoptosis determined by annexin V-FITC/PI staining by flow cytometry. (a) The H446 cells were treated with anlotinib (5 μM) and 5-FU (10 μM) or combination of both. (b) The apoptosis rate (%) included Q3 and Q4. All experiments were repeated three times. The bars represent of the three independent experiments. and compared with anlotinib.
(a) |
(b) |